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1. Introduction  
In the introductory chapter I will outline the concept of access to universal care and the role of 
nurses in implementing and managing antiretroviral treatment. I will proceed to discuss the 
purpose of the study with a focus on my hypothesis, specific objectives, type of research and 
finally the organisation of the dissertation. 
Globally in 2015 there were 36.7 million people living with HIV (PLWHA), of which 25.6 
million were in sub-Saharan Africa and approximately seven million in South Africa (SA). 1, 24 
Since the discovery of Human Immunodeficiency Virus (HIV) in 1981 “tens of millions of 
people” have died from Acquired Immune Deficiency Syndrome (AIDS). 2 
The World Health Organisation (WHO) in its efforts to reduce mortality introduced the concept 
of universal access to treatment for HIV by 2015, which also encompasses Millennium 
Development Goal 6.3 This goal focused on combating HIV, AIDS, malaria and other diseases .3  
 
 Background 
Primary health care nurses provide health care to thousands of patients both in rural and urban 
regions of SA and are a valuable resource for providing education, support and care for 
communities. 4, 5These nursing practitioners often work under circumstances where access to a 
medical doctor is a scarce commodity so they have to utilize their experience, skill and 
knowledge to provide good quality service to patients. 4, 5 
In September 2010 the South African government initiated a policy that allowed for the 
provision of antiretroviral medication by primary health care nurses to people living with HIV 
and AIDS (PLWHA). 4, 5 There are many challenges and lessons that can be learned from an 
established nurse-based rollout programme for ART. These programmes have been rolled out in 
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an effort to meet the demand of providing treatment to PLWHA and have shown to be successful 
in resource constrained settings. 3, 4,5,17 
In a setting like SA this study could provide valuable information on gaps or areas of weakness 
that currently exist in the system.  
 
 Purpose of the study 
The purpose of this study was to compare the outcomes of nurse initiated management of 
antiretroviral therapy (NIMART) in TB-HIV co-infected patients vs HIV mono-infected patients 
in an urban non-government organisation(NGO) funded clinic in KwaZulu-Natal (KZN), 
between  January 2010-December 2012. 
 
 Research Hypothesis: 
NIMART management of TB-HIV co-infected patients requires complex clinical care, and is 
associated with worse outcomes as compared to HIV mono-infected patients. 
 
 Specific Objectives 
The specific objectives of this study were designed to include a descriptive profile within a 
NIMART programme as well as an analysis of the differences between the two cohorts. The 
descriptive profile involved describing and comparing the patient demographic variables and the 
HIV and AIDS disease profile in TB-HIV co- infected patient’s vs HIV mono- infected patients. 
The difference between TB-HIV co-infected and HIV mono-infected patients  will be analysed 
in terms of : 
o Reasons for referrals of NIMART patients to the medical officer;  
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o Clinical outcomes; and 
o Mortality. 
 
 Type of research 
This was a health system research with a population based epidemiological component. 
 
 Definitions 
The definitions listed below indicate specific definitions and how these would apply to the study.  
o HIV WHO Staging: The WHO classification of HIV for adults and adolescents was used 
for the purpose of this study. We will consider this in the present document, the category of 
adults and adolescents aged 15 years and over for surveillance purposes. 16 
o Urban: Relating to characteristic of, or constituting a city. For the purpose of the study 
the word urban refers to the setting in the city of Durban. 
  
 Organisation of the dissertation 
This dissertation is presented in the Journal Article Manuscript Format approved by the 
University of KwaZulu-Natal. In place of presenting a ‘Results’ chapter, a Journal Article 
Manuscript, ready for submission to Journal of Public Health  for peer review is presented. 
The organisation of the chapters is discussed below. 
Chapter 1 focuses on a brief introduction, background, purpose of the study, the hypothesis, the 
objectives, type of research and definitions used. 
Chapter 2 comprises a detailed literature review and focuses on current literature available. 
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Chapter 3 comprises the journal article ready for submission to Journal of Public Health. 
Chapter 4 presents the synthesis of the study which is a review of the additional results that are 
not included in the journal article, the limitations of the study, possible bias as well as the 







 Literature Review 
The following section describes the background to the NIMART strategy, highlighting the need 
to overcome clinical staff shortages and initiatives to achieve the Millennium Development 
Goals with regard to HIV rollout. The clinical trial summaries reflect the outcomes of various 
NIMART programme and task shifting. Data was obtained by means of searches conducted on 
Google, Google scholar, PubMed and Cochrane data base review. Search terms used were 
‘NIMART’, ‘task shifting’, ‘WHO’, ‘Millennium Development Goals’, nurses’ views on 
NIMART, health workforce and TB-HIV treatment. 
 
 The World Health Organisation strategy 
In 2006 the World Health Organisation declared the sub–Saharan region of Africa to be in crisis 
because it had less than the minimum WHO recommendation of 2.3 doctors and nurses per 1 000 
patient population. 5 This shortage of doctors led to idea of decentralizing ART services to nurse-
led clinics which would improve patient access to HIV management and treatment. 5 
In 2008 the burden of HIV was expanding globally and the lack of highly trained personnel to 
administer the treatment lead the WHO to provide a global recommendation document of task 
shifting. 6 The document referred to shifting specific NIMART management tasks from doctors 
to nurses. Included in the tasks affected by this is determining the eligibility of patients for 
treatment, determining which line of therapy needs to be commenced, management of the side 
effects of treatment and the clinical monitoring of the patients. 5 
The document was proposed with the aim of overcoming the shortages of staff, providing 
increased access to ART and meeting the Millennium Development Goals. 6, 8 The sub-Saharan 
region was most affected by the HIV epidemic and task shifting would therefore prove to be 
beneficial here. 7 
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 Task shifting 
Task shifting involves the transference of certain tasks which were previously performed by 
highly skilled personnel such as doctors to less skilled personnel such as nurses. 6 Studies have 
shown that task shifting allows better access to HIV services with a result of greater efficiency of 
service delivery. 8 For example, the number of HIV treatment initiations doubled in Malawi due 
to task shifting .7 In Uganda task shifting resulted in an increase in enrolment of patients on to 
the ART programme by 20% .7  In Botswana the implementation of NIMART saw nearly 20 000 
patients receiving ART in rural areas by December 2007. 17  
A systematic review conducted by Callaghan et al. on 84 articles on task shifting for HIV care 
and treatment revealed that task shifting is cost effective and can offer good quality care to more 
patients than a doctor-based approach. 17 There are many facets involved in the costs of running a 
clinic for ART of which salaries are the largest component. 17 In a study carried out in South 
Africa the cost of the doctors’ salaries was estimated to be 42 percent of the total clinic cost. 17 
Task shifting reduced dependence on doctors which could lead to a reduction in ART           
clinic costs. 17 This could have equated to more surplus money to keep the clinic running, better 
facilities or an increase in the patient number that were receiving ART. The review also revealed 
that task shifting led to time saving. 17 This was based on the assumption that the time saved 
allowed senior staff to focus on the management of complicated patients and  a decrease in clinic 
waiting time with an ultimate reduction in loss to follow ups. 17 A study in Rwanda that analysed 
time saving in NIMART clinics revealed that task shifting would result in 183 percent increase 
in doctor capacity for tasks that are non-HIV related.17 In their study Emdin et al .found that task 
shifting contributed to better patient compliance and reduced loss to follow up. They attributed 
this to the fact that access to treatment was closer to the patient’s home and time off work and 
travel costs were reduced. 7  
In 2006 a decentralized approach of ART from hospital to primary health care clinics was 
adopted in rural Lusikisiki in South Africa to mitigate the effects of staff shortages. 19 This model 
resulted in rapid initiation of ART and better treatment retention of follow up patients (2 percent 
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vs 19 percent loss to follow-up). 19   In addition, there was 95 percent coverage of people 
receiving ART in 2006 under this model of care. 19 
The outcomes of task shifting in the sub-Saharan region have yielded positive clinical     
outcomes. 17 Uganda showed good clinical outcomes just 2 years into their NIMART 
programme. Rwanda, Lesotho and South Africa have also reported good clinical outcomes as 
well as retention on ART. 17   
The impact of task shifting and ultimately ART scale up was also examined from a provider’s 
perspective in a health care worker survey that took place in 2 South African provinces 
(KwaZulu-Natal and Western Cape) in 2006. 20The survey was completed by 269 health care 
professionals and showed that ART scale up with nurses was not perceived to impose an 
additional burden in the health system. On the contrary, greater levels of job satisfaction was 
present. 20 One possible explanation is that as a result of being responsible for providing 
lifesaving medication, the nurses viewed themselves as a critical component in the treatment 
paradigm of HIV patients. 20 This ultimately boosted the morale of the healthcare personnel. 20 
Work benefits like remuneration also led to job satisfaction. The study also revealed that workers 
in the ART clinics reported a lighter workload with higher level of staffing and lower sick leave 
rates. 20 
The task shifting model did not only apply to nurses for ART management but also other 
community health workers. 17 The sub-Saharan region went further than task shifting within a 
clinical environment to the introduction of community-based services that were outside the clinic 
setting. 17 The results from a trial in Uganda which compared home-based care through lay 
providers with facility-based care in ART found that the rates for viral load suppression, failure 
and mortality were similar. 17 Compliance with ART is imperative for a patient to achieve viral 
load suppression and overall survival. Two studies in Malawi which introduced community 
based lay providers as a support to facility based ART treatment revealed different results. 17 One 
study showed better survival and retention rates on ART compared with patients who did not 
receive this support. 17 However, another Malawian study showed contrary results where 
community health care workers were not able to identify eligible patients for ART as efficiently 
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as doctors’ could. 17 These results reveal that task shifting is beneficial but also needs to be 
closely monitored to establish loop holes in the system and then provide guidance and training to 
ensure successful outcomes. 
Ongoing education and training of staff on ART practices has been identified as a means to 
overcome the challenges faced in task shifting. 17 This was demonstrated in a study done in 
South Africa on community health care workers. 17Similarily in Zambia 85 percent of lay 
counsellors identified extra training on ART as a means to improve service delivery. 17 A 
descriptive analysis of the 1 479 HIV-TB queries received from nurses in 2012 at the “South 
African national HIV and TB health care worker hotline” identified NIMART, drug side effects 
and laboratory result interpretation as the most common queries received. 18 
Zachariah et al proposed the following in their paper on task shifting in sub-Saharan Africa. 21 
The scale up of ART services to provide lifesaving treatment to many more people was seen as a 
better option than a doctor-based facility in terms of sustainability and cost effectiveness. 21 They 
proposed some of the challenges that should be addressed to sustain such a model is maintaining 
the quality of health care, staff satisfaction and motivation and preventing staff deaths from HIV 
itself. 21 The task shifting concept was introduced in South Africa in 2010. 9 
 
 National Strategic Plan and NIMART 
South Africa has a quadruple burden of disease which comprises communicable diseases such as 
HIV, AIDS and TB, maternal and child morbidity and mortality, non-communicable disease and 
violence, injuries and trauma. 9 
In 2000 in order to combat the problem of poor health, poverty, hunger, inequalities in gender 
and lack of basic services such as clean water the United Nations adopted a UN Millennium 
declaration of which 189 countries adopted. 21 This declaration led to development of eight 
Millennium development goals that were pledged to be achieved by 2015. 21 
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In line with the Millennium Development Goal 6 (combating HIV, AIDS, malaria and other 
diseases), and to address the SA burden of disease, the National Strategic Plan 2009-2014 for 
Health was developed. 3, 9 One of the imperatives was to speed up the implementation of  
HIV / AIDS and Sexually Transmitted Infections National Strategic Plan from 2007-2011 with 
an increased focus on TB and other communicable diseases. 9 
An analysis of South Africa’s’ challenges brought on the realisation that HIV was a major 
contributor to morbidity and mortality and action needed to be taken to improve this outcome. 9 
Thus the government rolled out the NIMART programme in 2010. 9 From 2010 to 2013 the 
number of people who were initiated on HIV treatment increased from 923 000 to 1.9 million .9 
The goal in South Africa is to ultimately achieve an HIV and AIDS free generation under the age 
of 20 by 2030 as stipulated in National Development Plan. 9 
 
 Department of Health (DOH) ART guidelines  
In South Africa the decade of HIV denialism was opposed by the actions of the Treatment 
Action Campaign (TAC) who exerted pressure on the existing South African government to 
provide treatment and care for PLWHA. 10   In 2010 ART was provided to all PLWHA that had a 
CD4 count of 200 cells per microliter (µL) or less, with the exclusion of TB co-infected and 
pregnant females who were initiated on treatment with higher CD4 count of 350 cell/ µL. 10 
By 2011 the guidelines were updated for ART initiation to include all PLWHA to start at CD4 
counts of 350 cells/ µL or less. 10 By 2013 the guidelines were updated once again to initiate 
treatment with antiretroviral drugs irrespective of their CD4 for PLWHA co- infected with TB 
and all pregnant women. 10   The massive shift in initiating ART at an earlier CD4 count meant a 
scale up of HIV treatment programmes that required trained personal .14 The SA government has 
introduced an update to the guideline for ART initiation in 2016 by advocating that all PLWHA 
start ART irrespective of their CD4 count. 23 The availability of trained personnel is more 
imperative as we gearing for the largest programme for ART initiation in SA. 
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  Evidence on NIMART 
The Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) trial, 
conducted in South Africa, was a parallel, open label cluster randomised controlled trial (RCT) 
conducted in 31 public sector clinics in the Free State during the period of 2008 to 2010. 11   
There was random allocation of the different clinics into an intervention arm (16 clinics) and a 
control arm (15 clinics). 11 Patient were assigned to either cohort 1 which consisted of adult 
patients waiting to start ART, or cohort 2 which consisted of patients had already been on ART 
for at least six months. 11  
Cohort 1 inclusion criteria were a CD4 count of ≤ 350 cells per μL, making them eligible for 
ART. These patients were monitored for a year following enrolment. 11 Failure of patients to 
return to the clinic following enrolment resulted in them being excluded from the study. 11 
Informed consent was received from clinic staff and not from the patients as the trial was 
studying a managerial procedure. 11 However the patients were informed of the study and its      
interventions. 11 The control arm of the trial employed the current standard of care in the South 
African public health sector for HIV/AIDS treatment. Patients that tested positive with the HIV 
virus were seen by nurses to determine their eligibility for treatment which was a                   
CD4 count < 200 cells per μL, WHO Stage 4 condition or were pregnant with a CD4 count < 350 
cells per μL. 11 These patients were seen by a doctor who initiated treatment. 11 The follow-up 
visits could be done in rural clinics near the patient’s home by nurses who received the 
medication from hospital pharmacy for dispensing. 11 
The clinics which had been randomly selected to the intervention arm had employed the protocol 
for the STRETCH trial. Nurses were allowed to initiate and prescribe ART for the eligible 
patients. 11 The nurses had been provided with a minimum of four ART training sessions on the 
prescription of ART, the treatment algorithm, the management and monitoring of side effects of 
the medication and when to refer the patient to a doctor. 11 Data was initially collected on paper 
and then transferred to an electronic data base. 11 
The two cohorts differed in terms of primary outcomes. Cohort one had an outcome of time to 
death and cohort two was undetectable viral loads 12 months after enrolment .11  The undetected 
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viral load was defined as a viral load < 400 copies per ml. 11 Cohort one had 9252 participants 
and cohort two had 6231 participants. 11  
The results showed that patients in cohort one had a 47% less chance of death if they were on 
ART than those who were not on ART, and the study was able to attain the goal of viral load 
suppression in patients on treatment. 11 There was no single outcome that was worse in the 
intervention group as compared to the control group. This trial demonstrated that task shifting is 
possible and that ART initiation and follow up can be done safely by nurses. 11  
Problems identified in the trial included nurses’ reluctance to initiate treatment when there was a 
doctor available in the clinic. The poor delivery of ART to clinics resulted in the additional 
problem of lack of treatment available in clinics .This hampered the nurses’ ability to adequately 
start ART. 11 
The evidence for NIMART is further highlighted by another RCT that was conducted by Sanne 
et al. in South Africa. 12 The trial looked at doctor versus nurse management of HIV infected 
persons in primary health care clinics and was powered for non-inferiority. 12   There was an 
intervention arm and control arm to the trial. 12 There were 404 patients randomly selected for the 
intervention arm and 408 patients for the control arm of the trial. 12 The inclusion criteria were 
adult patients that had been on ART for less than six weeks. 12 The follow up period of the 
patients was 120 weeks. 12 Study end points were mortality, virological failure, loss to follow 
ups, toxicity failure, defaulting visits between the nurse- and doctor-managed groups. 12 The 
study concluded that no significant difference was found between these end points. 12 
 
 Sustainability of NIMART 
The success of NIMART has been proven in both the public sector as well as in non-government 
organisations (NGO’S) with private funding. A study conducted between 2004 and 2010 by 
Naranbhai et al. in a rural HIV clinic in KZN, showed that task shifting was able to positively 
influence long term treatment outcomes. 13 The nurses were not involved in ART initiation, 
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rather in the follow up of treatment initiated patients. 13 There was an onsite doctor for ART 
initiation and for the management of complications. 13. The results showed that virological 
suppression was achieved in approximately 90% of patients during the study period of 60 
months. 13 
The success of NIMART has been well demonstrated in the literature. However, the barriers to 
NIMART also need to be addressed. The Foundation of Professional Development (FPD) 
conducted a study in seven provinces in SA between October 2010 and March 2011 which 
looked at the number of nurses that were implementing NIMART within two months of patient’s 
attending the clinic. The endpoints were quality of care and barriers to NIMART 
implementation.  15 The results indicated that only 72% of nurses initiated treatment. 15 The 
barriers to initiation of treatment identified in this study were a lack of mentorship; lack of 
training in pharmacology; lack of clinical skills and shortage of primary health care nurses. 15 A 
cross-sectional quality of care study in Khayelitsha in 2011 to 2012 showed that a clinical 
mentorship programme improved clinical skills of nurses and boosted their confidence in 
initiating patients on to ART. 14 The challenges highlighted within the above trials provides an 
insight into the operational challenges which have to be overcome in the implementation of these 
programmes in South Africa. 
 
 Summary of literature review 
Task shifting has been adapted and has been shown to be effective and sustainable personnel 
strategy in the treatment of HIV patients. NIMART implementation has been introduced  
In SA, however, some barriers still exist with regards to operational challenges within the 
existing system. Most of the literature available addresses success of task shifting and NIMART 
with regards to numbers’ initiated, clinical outcomes, mortality, adherence, cost effectiveness, 
and challenges encountered by nurses.  
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Tuberculosis is one the most common infection seen in PLWHA and is the major cause of death 
in PLWHA. 19, 22 The identification of both pulmonary, smear negative and extra pulmonary TB 
is critical in providing improved clinical outcomes in PLWHA. 22 There is a gap in data available 
on referrals of adverse events to medical officers especially in TB-HIV co-infected patients. 
This paper aims to look at complexities and challenges associated with TB-HIV co-infection by 
focusing on clinical outcomes, mortality and adverse events seen and referred to medical officers 




Chapter 3  
 Journal article manuscript 
In this chapter I am presenting a Journal Article Manuscript which describes the new research 
that I completed as part of my Master of Public Health degree at the University of KwaZulu-
Natal. I have prepared the article to be submitted to the Journal of Public Health. The guide for 
author submission for the Journal of Public Health is attached as annexure 6.4.  This guide 
determined the format, layout and word count of the article, which might be different to rest of 
the dissertation.  
The type of article is an original research article and should be 3000 words. Although this article 
has not yet been published it is ready to be sent off to the editors for peer review.  I have 
included the Tables and Figures where I think they could be included in the final published 
article – as opposed to being submitted separately as required by the editors. 
There are some additional results, discussion and limitations which were not included in the 
article in Chapter 4 of this dissertation. 
 Author requirements 
 Below I have summarized briefly the author requirement for the article. 
1. The article should be maximum of 3000 words.   
2. Title page should have all authors, their main degrees (max of two), name and location of 
institution where study was done and contact details. 
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Managing HIV associated Tuberculosis in people living with HIV and AIDS (PLWHA) requires 
complex clinical care, is associated with adverse clinical outcomes and warrants referral to 
medical officers as compared to those that are HIV mono-infected. 
The objectives of this study are to compare the clinical outcomes, mortality and reasons for 
referral in two groups of PLWHA, with Tuberculosis associated with HIV (TB-HIV) and HIV 
mono-infection. The study was performed in a non-governmental funded, nurse initiated 
management of antiretroviral (NIMART) programme in a province of South Africa from January 
2010 to December 2012.   
Study design 
An observational, retrospective, analytic cohort study design was used.  
Method 
Both groups of PLWHA were commenced on a once daily ART regimen and enrolled into the 
NIMART programme by two professional nurses with an onsite medical officer to attend to 
complex cases. The two groups were classified for TB at baseline based on active TB infection 
and not latent TB infection .Data was collated from case report forms stored on a special 
electronic data base and was processed and analysed using appropriate biostatistics.  
Results 
A total of 1096 PLWHA that were HIV mono-infected 622 (57%) and 474 (43%) TB-HIV co-
infected were enrolled and followed up for 18 to 24 months. The two groups were significantly 
different in terms of gender, body mass index, viral load and disease staging at baseline. Both 
groups maintained a sustained CD4 count increase and viral load suppression during the period 
of the programme. There were 35 deaths in the TB-HIV co-infected group with a mortality rate 
(MR) 7.4 per 100 person years [95% Confidence Interval (CI): 5.1 - 10.3] and 38 deaths in the 
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HIV mono-infected group with a MR of 7.8 per 100 person years at 24 months (95% CI: 5.5 - 
10.7). These mortality rates were not significantly different. Multivariate analysis on predictors 
of mortality for all PLWHA revealed that the risk of mortality was increased if there was a 
CD4<50 cells/mm3 (p=0.003) and WHO stage 4 condition (p>0.001) for both groups. There 
were a total of 1867 adverse events (968 in the TB-HIV co-infected and 899 in the HIV mono- 
infected group). There were 963 and 808 doctor referrals from 370 and 338 PLWHA from the 
TB-HIV co-infected and HIV mono-infected groups respectively. The most common reason for 
referral for the TB-HIV co-infected group were for peripheral neuropathy (61); rash (41) and 
TB- Immune Reconstitution Inflammatory Syndrome [IRIS] (40). The most common referrals 
for the HIV mono-infected group were for peripheral neuropathy (35); papular pruritic eruption 
(21) and upper respiratory tract infections (20). 
Conclusion 
Our study showed that the NIMART is effective for PLWHA that are TB-HIV co-infected as it is 
for mono-infected patients when access to a medical officer for referral is available. 
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There were 36 million people living with Human Immune Deficiency Syndrome (HIV) and 
Acquired Immunodeficiency Syndrome (AIDS) (PLWHA) globally in 2015, with 26 million in 
sub-Saharan Africa and approximately 7 million in South Africa (SA). 1, 15 The burden of HIV 
was expanding globally in 2008 and the lack of highly trained personal to administer the 
treatment, led the World Health Organisation (WHO) to recommend task shifting, the 
transference of certain tasks which were performed by highly skilled personal such as doctors to 
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less skilled personal such as nurses. 2 Task shifting aims to overcome the shortages of staff and 
being able to provide increased access to antiretroviral therapy (ART) and meet the Millennium 
Development Goals. 2, 3    
There was a realisation in SA that HIV infection was a major contributor to morbidity and 
mortality and as part of the strategy to address the problem NIMART was commenced in 2010. 4 
From 2010 to 2013, the number of people initiated on ART increased from 923 000 to 1.9 
million. 4 The SA government introduced an update to the guideline for ART initiation in 2016 
by advocating that all PLWHA start ART irrespective of their CD4 count. 10 The availability of 
trained health care personnel is essential in order to deliver care for the large number of PLWHA 
who need ART in SA. 
The effectiveness of NIMART was shown in the STRETCH trial “Streamlining Tasks and Roles 
to Expand Treatment and Care for HIV”, a parallel; cluster randomised controlled trial conducted 
in 16 public sector clinics in the Free State during the period of 2008 to 2010. 5     
A study done by Naranbhai et al. in a rural HIV clinic in the KwaZulu-Natal (KZN) province 
showed  that task shifting in NIMART was able to improve long term treatment outcomes. 6 
Virological suppression was achieved in 89-97% of patients for period of 60 months and there 
was 82% retention (p<0.0001) up to 24 months. 6 
Tuberculosis is one the most common infections seen in PLWHA and is the major cause of death 
in PLWHA. 11, 12 The identification of both pulmonary and extra pulmonary TB is critical in 
providing improved clinical outcomes in PLWHA. 22 There is a gap in the data available on 
referrals of adverse events to medical officers, especially in TB-HIV co-infected patients. 
This paper aims to look at complexities and challenges associated with TB-HIV co-infection by 
focusing on clinical outcomes, mortality and adverse events seen and referred to medical officers 
as compared to HIV mono –infection in a non-governmental organisation (NGO) funded, nurse 
initiated management of antiretroviral programme in KZN(a province in SA) from January 2010 
to December 2012.   
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Our study setting was an urban HIV treatment clinic in KZN run by an NGO, Centre for Aids 
Prevention Research in Southern Africa (CAPRISA). In 2010, in line with the National Health 
Department’s policy, nurses began to initiate ART. The medical officer were employed full time 
and their  role was to be a mentor, review all laboratory results, and attend to patients with 
treatment regimen failures, hospital admission, and referrals from nurses. The programme had 
the services of lay counsellors to assist with adherence to treatment and trackers to trace study 
participants that missed scheduled visits. 
Method 
An observational, retrospective, analytic cohort study design was used. The study population 
consisted of naïve adult PLWHA, either with TB-HIV co-infection or HIV mono- infection. The 
two groups were classified for TB at baseline based on active TB infection and not latent TB 
infection .The PLWHA were allocated into the respective groups based on their TB status at 
enrolment into the ART programme. We decided to use a sample size of 1000 which increased 
the power to 85%, however we finally settled on including all the PLWHA (1096) for the study 
period as the data was readily available. 
For the participants in this study NIMART was initiated in both groups. Detailed records were 
collected by nurses on a case report form (CRF). Data was quality reviewed by data manager and 
stored on an electronic data base. 
The data was analysed using unpaired t-test, and Wilcoxon rank sum test for continuous data and 
Fisher’s exact test for categorical data to compare demographics and clinical characteristics 
between the 2 groups. Data was censored at 24 months post ART initiation. Kaplan-Meier was 
used to construct survival curves and compare them using the log-rank test. Predictors of 
mortality were assessed through both univariate and multivariate proportional hazards 
regression. P values less than 0.05 were considered statistically significant. All analyses were 
conducted using SAS, version 9.4 (SAS Institute INC., Cary). 
An adverse event in study was defined as any untoward event that occurred to a participant after 
starting ART and was graded via the Division of Aids (DAIDS) grading system. 
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Ethics approval was obtained from the University of KwaZulu-Natal, South Africa Biomedical 
Research Ethics Committee. BE 494/15 - Sub-study of E248/050. Informed consent was waived 
by ethics committee. 
 
Results 
A total of 1096 PLWHA were enrolled in the two year study. Most (622, 57%) were HIV mono-
infected and 474 (43%) were TB-HIV co-infected.  
 
Baseline characteristics 
The baseline characteristics analysed for both groups were body mass index (BMI), viral load 
(VL), World Health Organisation (WHO) disease stage, age, gender and a previous history of 
TB. The TB-HIV group had significantly lower (BMI) [21.4 (Interquartile Range (IQR): 19.2 - 
24.1) compared to the HIV-mono infected group. (23.9 - IQR: 21.0 - 27.7) (p <0.001); a higher 
mean VL (5.1 vs 4.8, p <0.001); more WHO Stage 4 disease (23.8% vs 11%, p <0.001); and, 
more males (54% vs 40 %, p <0.001) (Table 1). There was no difference in age and CD4 count 
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Age (years), n (%)     0.565 
<24 15  3.2 23  3.7  
24-34 216  45.6 300  48.2  
35+ 243  51.3 299  48.1  
Women 218  46.0 373  60.0 <0.001 
Men 256  54.0 249  40.0  
BMI(kg/m2), median 21.4  IQR    
19.2-24.1 





144  IQR  
72 -228 
146  IQR  
77 - 210 
0.512 
CD4 count     0.482 
<50 69  15.5 96  16.5  
50-200 231  51.8 316 54.3  
>200 146  32.7 170  29.2  
Log VL, mean(SD) 5.1  0.9 4.8  0.7 <0.001 
WHO Stage 1-3 361  76.2 549  89 <0.001 
WHO Stage 4 113  23.8 68  11  
Previous history of TB 120  25.8 182  30.8 0.086 
 
Clinical outcomes 
The clinical outcomes were assessed by looking at the mean CD4 count increase and VL 
suppression at different time points. The mean CD4 count increase and VL suppression (< 400 
copies/ml) were not significantly different between both the groups. At month 12 the mean CD4 
count increase in TB-HIV co-infected group [n=302] was 200 cells/mm3 (95% CI: 174-226) and 
HIV mono infected group [n=215] was 184 cells/mm3 (95% CI: 166-202) p = 0.291). The 
proportion of PLWHA with a viral load suppression at month 12 in TB-HIV co-infected group 
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A key outcome in study was mortality. There were 35 deaths in the TB-HIV co-infected group 
(MR - 7.4 per 100 person years (95% CI: 5.1 - 10.3) and 38 deaths in the HIV mono-infected 
group (MR - 7.8 per 100 person years (95% CI: 5.5 - 10.7) at 24 months. Mortality rate among 
PLWHA who are mono-infected was slightly higher than for those who were co-infected (Table 
2). However, these mortality rates were not significantly different. The Kaplan-Meier curve for 




Table 2: Mortality rate (MR) for TB-HIV co-infected and HIV mono-infected at 6, 12, 18 
and 24 months of study follow-up 
 







































































































































































Figure 1: Kaplan-Meier curve for probability of death for TB-HIV co-infected and HIV 
mono-infected PLWHA over 24 months. 
 
Predictors of death 
A multivariate analysis for the predictors of death was done for the entire study. One of the 
findings was that the group was not a predictor of death [HR 0.84 (95% CI: 0.51-1.39) p = 
0.503], (Table 3). The risk of death was increased if there was a CD4<50 cells/mm3 as compared 
to CD4 > 200 cells/mm3 [HR 3.17 (95% CI: 1.47-6.85) p=0.003] and PLWHA who were 
enrolled into the programme with WHO stage 4 conditions were at high risk of death [HR 3.04 
(95% CI: 1.84-5.03) p<0.001]. Adjusted proportional hazards regression analysis showed that 






Table 3: Multivariate analysis of the predictors of mortality for the study 
 
The analysis on adverse event (AE) looked at total number of adverse events seen by both nurses 
and medical officers and nurse referrals to medical officer in both groups. There was a total of 
1867 AE with 968 from 404 in the TB-HIV co-infected and 899 from 410 in the TB-HIV mono-
HIV infected group. There were doctor referrals of 963 from 370 in the TB-HIV co-infected and 
808 from 338 in the mono-HIV infected group. 
The adverse events were categorised according to anatomical systems: respiratory, ear nose and 
throat (ENT), gastrointestinal (GIT), cardiovascular (CVS), central nervous system (CNS), anal, 
genitourinary (GUT), oral and mouth, ophthalmic and others (HIV nephropathy, TB-IRIS, HIV 
Variable at ART initiation Univariate Multivariate 
  HR 95% CI p-value HR 95% CI p-
value 














Gender (ref: women) Male  2.00 1.24-3.21 0.004 1.99 1.17-3.38 0.011 
Age ( per 5 year 
increase)  0.97 
 





CD4+ cell count 
(ref:>200), cells/mm3 <50  3.64 
 





 50-200  1.56 0.81-3.01 0.181 1.86 0.91-3.82 0.090 
Viral load (log10 
copies/ml)  1.16 
 





WHO stage (ref: 1-3) Stage 4 3.59 2.25-5.74 <0.001 3.04 1.84-5.03 <0.001 
Past history of TB 
(ref: No) Yes 1.19 
 







arthroplasty, peripheral neuropathy, TB lymphadenitis and lymphoma). The most common AE 
seen for both TB-HIV and HIV mono-infected groups were peripheral neuropathy, rash, TB-
IRIS and oral thrush (Table 4).  
The most common reason for referrals for TB-HIV co-infected group were peripheral neuropathy 
(61), rash (41) and TB-IRIS (40). The most common referrals for HIV mono-infected group were 


















Table 4: The most common adverse events seen in study by either doctor or nurse, 
including referral to clinician for both TB-HIV co-infected and HIV mono-infected group. 
Type of AE 
AE Referrals 
TB-HIV HIV  TB-HIV HIV  
Respiratory         
Lower respiratory tract infection 30 24 17 20 
ENT         
Upper respiratory tract infection 59 74 17 21 
GIT         
Hepatitis 3 2 3 1 
CNS         
Meningitis 4 0 3 0 
Cardiovascular         
Pericarditis 1 2 1 2 
Ophthalmology         
Conjunctivitis 4 2 1 0 
Skin         
Rash 41 30 41 14 
Papular pruritic eruptions 24 19 24 21 
Herpes zoster/shingles 8 7 5 6 
Anal         
Anal fistula/fissure 0 2 0 2 
Genitourinary         
Urinary tract infection   15 19 12 7 
Oral and mouth         
Oral thrush 23 25 22 20 
Other     
Peripheral neuropathy 61 35 61 35 
TB IRIS 39 13 40 11 
     
 
The reasons for study participants in this cohort terminating their involvement in the study 





The World Health Organisation introduced task shifting for the initiation and management of 
ART from medical officers to nurses in resource constrained countries in 2008. 2 Integrating task 
shifting for the initiation and management of ART enables more patients to be treated and 
managed in the healthcare system. This is critical in resource constrained countries, like South 
Africa.  
Our study looked at the effectiveness of NIMART in an NGO setting with the assistance of 
medical officers for referral of PLWHA by focusing on TB-HIV co-infection vs HIV mono-
infection and complexities associated with the dual diseases. The key objectives of the study was 
to compare the clinical outcomes, mortality and reasons for referral in two groups of PLWHA – 
one with Tuberculosis with HIV (TB-HIV) and the other with HIV mono-infection in a NGO 
funded , NIMART  programme in KZN, South Africa. 
The clinical outcomes of our study showed no overall difference in CD4 count increase and viral 
load suppression between the TB-HIV co-infected and HIV mono-infected PLWHA.  Naranbai 
et al.  demonstrated a rise in CD4 count in their NIMART programme from baseline and 
between 88.9-97.4% of the PLWHA had maintained their virologic suppression until 60 months. 
6 The STRETCH trial done in SA showed that there was no difference in viral load suppression 
between nurse led and doctor led groups in the cohort that was initiated by doctors and followed 
up by nurses, however in cohort run by nurses alone there was sub optimal viral load 
suppression. 5  
Mortality rate among PLWHA who were HIV mono-infected was slightly higher than for those 
who were TB-HIV co-infected with in our study. A possible explanation the MR was higher in 
mono-infected could be due to undiagnosed TB. However, these mortality rates were not 
significantly different. Naranbai et al. also reported significant decrease in mortality by 24 
months for PLWHA being monitored by nurses. 6 The STRETCH trial showed there was no 
significant difference in mortality in the cohort one (CD4 below or equal to 350 per μL.) for both 
the intervention and control group, however in cohort two (PLWHA with CD4 < 200 per μL.) 
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there was a decrease in mortality in intervention group as compared to the control group (HR 
0.76, 95% CI 0.60-0.97). 5   
The predictors of death in our study were PLWHA who were enrolled with CD4<50 cells/mm3, 
male gender and WHO stage 4 condition into the programme. These parameters are in keeping 
with another study done in Durban, SA that looked at predictors of mortality in PLWHA starting 
ART. This retrospective cohort study showed the predictors of death were poor laboratory 
markers (CD4< 50µL, haemoglobin count less than 8g/dl) and clinical parameters such as a 
history of oral thrush and cryptococcal meningitis. 8 The study also confirmed that a history of 
TB was not a significant predictor of death, a finding that was consistent with our study (p=0.917 
for past history of TB). 8 The male gender as a predictor of death is contrary to other studies .A 
study done by Dominique et al on HIV-TB infected PLWHA showed that the female gender is 
an independent risk factor of mortality.16 A further study in Ethiopia on PLWHA with HIV-TB 
showed that female sex workers was also seen as a predictor of death.17 
The adverse events seen were consistent with PLWHA on TB and HIV treatment. Majority of 
referrals (963) were from TB-HIV co-infected. A study done on nurse queries in the NIMART 
programme revealed that the most common queries to the call centre was on laboratory result 
interpretation before ART initiation, 18% on adverse drug reactions and 7% on TB co-infection. 
9 Green et al reported a low level of referrals to medical officers from nurses in their study and 
cited that a possible reason was that there was a low level of medical officer presence in the 
clinics. 7   Contrary, our study showed a high level of referral most likely due to presence of a 
medical officer on a permanent basis and in some cases the scripting of schedule medication 
such as fluconazole for resistant oral thrush may have prompted the nurses to refer these 
PLWHA. 
We recognise the limitations of our study, which were that not all case report forms had 
diagnosis for PLWHA and as such only symptoms were reported, all laboratory toxicities where 
not captured as such these tests could not be evaluated from data captured. Sick PLWHA may 
have been triaged by sister in charge to medical officers before even being seen by a nurse thus 
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limiting nurse’s knowledge on their management, the data was limited to an NGO clinic with no 
comparison to a DOH clinic.   
 
Conclusion 
In conclusion the findings of this study supports the WHO concept of task shifting and the 
STRETCH trial finding on effectiveness of the NIMART programme with regards to clinical 
outcomes and mortality. Our study showed that the NIMART is effective for PLWHA that are 
TB-HIV co-infected as it is for mono-infected patients when access to a medical officer for 
referral is available. We recommend training on ART related adverse events on dual therapy 
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Chapter 4  
 Synthesis, limitations, conclusion and recommendations 
In this chapter I will present some additional results from the study (synthesis) that could not be 
included in the journal article, the limitations of the study, assess validity with possible bias as 
well as the conclusions and overall recommendations additional to those that are presented in the 
journal article. 
The World Health Organisation introduced task shifting for the initiation and management of 
ART from medical officers to nurses in resource constrained countries in 2008. 6 South Africa 
introduced task shifting in 2010 when the Nurse Initiated Management of Antiretroviral Therapy 
programme was rolled out. 4, 5 The STRETCH trial provided evidence of the efficacy of task 
shifting in South Africa. 11   Our study which used an observational analytic cohort study design 
looked at the effectiveness of NIMART in an NGO setting with the assistance of medical 
officers for referral of PLWHA with complications of their therapy. A total of 1096 ART naïve 
participants, 474 HIV-TB co-infected and 622 HIV mono-infected were included in the study. 
Both groups were initiated on a once daily ART regimen (3TC, EFV, DDI/TDF) by two 
professional nurses during the study period .Once the programme lifespan of this NGO 
sponsored programme had been reached (18-24 months from initiation of ART) those PLWHA 
who had been stabilized on therapy were transferred to neighbouring government clinics to 
continue with the management of their HIV infection. 
 
 Additional data for discussion 
The reasons for study participants in this cohort terminating their involvement in the study 
included death, defaulting treatment, relocating, terminating for personal reasons and other 
reasons (Table 5). Most participants [402(84.8%) HIV-TB co-infected and 544(87.5%) HIV 
mono -infected] were transferred to neighbouring government clinics to continue with their care. 
Slightly higher numbers of PLWHA defaulted treatment in the HIV-TB co-infected group when 
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compared to the HIV-monotherapy group [18 (3.8%) vs 13 (2.1%)], however, this was not 
statistically significant. This finding is clinical significant as it could be related to possible side 
effects and pill burden of both treatments that could explain the reason for defaulting treatment.  
 
Table 5: Reasons for termination of TB-HIV co-infected and HIV mono-infected from the 














Death 35 7.4 39 6.3 0.469 
Defaulted 18 3.8 13 2.1 0.100 
Relocated 5 1.1 13 2.1 0.164 
Transferred 402 84.8 544 87.5 0.215 
Patient decision 5 1.1 8 1.3 0.786 




The limitations of the study are categorised as limitations related to measurement validity, 
statistical conclusion validity, internal validity which looks at bias and confounding as well as 
external validity. 
 
4.2.1.1 Measurement validity 
The analysis was done from information stored in an electronic data base. The data collected 
from CRF was quality reviewed by a data capturer before they were submitted to the electronic 
data base. The data management team did a second level of checking of the CRF before the 
information was stored in data base as part of quality control for the CAT programme. 
Not all case report forms had diagnosis for PLWHA and as such only symptoms were reported. 
Laboratory results for liver function, full blood count, urea and electrolytes, amylase, lipase and 
hepatitis B were not captured on the CRF. Hence laboratory toxicities for these tests could not be 
evaluated from data captured unless the prescriber felt it needed to be reported.  
 
4.2.1.2  Statistical Conclusion validity 
Statistical validity was maintained by initially choosing a sample size of 748 PLWHA with a 
power of 80% to detect a difference between 5.1% and 10.7% mortality among HIV mono-
infected and TB-HIV co-infected PLWHA respectively. This was based on the available 
literature on mortality concerning TB-HIV co-infected and HIV mono-infected PLWHA. We 
then decided to use a sample size of 1000 which increased the power to 85%, however, we 





4.2.1.3 Internal validity 
Selection Bias: 
The chance of selection bias was minimised as the study sample comprised a census of all the 
PLWHA recruited to be part of the CAT programme for the period of Jan 2010 to Dec 2012 in a 
single NGO funded clinic. However selection bias did occur as there were PLWHA that did not 
complete follow up  for the entire 24 months due to reasons of defaulting treatment, relocated to 
other areas, left the clinic on their own volition and for some other – non HIV related reasons. 
This would have resulted in non-differential misclassification which would have reduced the 
sample size (precision) which would have reduced the level of association towards the null.  
 
Information Bias 
Although the CRF’S were quality reviewed before being entered into the electronic data base the 
chance of information bias does exist as data was only verified from one source and depended on 
attending medical officers or nurse perspective as to what was important to transcribe on the 
CRF. Laboratory results for CD4 count and viral load were based on validated sensitive and 










The multivariate analysis for predictors of death accounted for possible confounders. The 
possible confounders we adjusted for were gender, age, CD4 count, VL, WHO stage and past 
history of TB. Other unmeasured confounders that could be analysed are social factors such as 
poverty, unemployment, overcrowding and comorbid conditions such as diabetes, and 
autoimmune disease.  
 
4.2.1.5 External validity 
The advantage of this observational study is that it allowed a direct observation of the PLWHA 
and clinic staff in a setting that was not manipulated by rules bound to a randomised clinical trial. 
The programme had special teams called trackers to locate patients that missed their visit 
irrespective of which cohort they were in .This study however was conducted in an NGO setting 
with adequate funding and staffing with a possibility that the results may not be generalised to all 
clinics as it lacked a comparison to Department of Health clinics. 
 
 Recommendations 
Our study was an observational, retrospective study which if allowed to do it again we would 
change a few aspects described below.  
Despite the limitations with an NGO setting, NGOs’ have the freedom and financial support to 
provide sustainable models of care and innovation. 
Study design 
The retrospective study limited us in available data from CRF and cannot accommodate for 
missing data. We recommend a prospective study with set variables with a specifically designed 
CRF to collect data required as well as a comparison with a Department of Health clinic. We also 
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recommend a pilot study be done to which can assist with design of CRF and aid in reducing 
information bias. We, however, did not do this for our study. 
Data Collection and interpretation 
In an effort to reduce information bias the CRF would be designed to reflect final diagnosis, set 
laboratory test abnormality outside of CD4 count and VL, referrals to hospital with details on the 
hospitalization. Data verification can be conducted with dual data sources NIMART log sheets 
and CRF. 
The recommendations for study design and data collection highlight the need for further more 
detailed research. 
Recommendation to health services 
Our study showed that the NIMART is effective for PLWHA that are TB-HIV co-infected as it is 
for mono-infected patients when access to a medical officer for referral is available. 
Regular training on ART related adverse events on dual therapy should be conducted regularly to 
equip nurses with knowledge and confidence to identify and treat these events. 
 
 Conclusion 
The study evaluated all PLWHA for period of two years with an initial hypothesis that NIMART 
management of TB-HIV co-infected patients requires complex clinical care, is associated with 
adverse clinical outcomes and warrants referral to medical officers as compared to HIV mono-
infected patients. However, our study showed that the mortality rate in both groups were similar, 
clinical outcomes improved by 6 ,12,18 and 24 months in both groups and nurses referred more 
adverse events to the medical officers for the TB-HIV co-infected group. A nurse run 





 Summary  
This chapter focused on findings that were not discussed in the journal article as well as the 
study limitations, conclusion and recommendations. The statistical analysis for our study 
included a descriptive and analytical component. The reasons for termination showed no 
statistical significance, however clinical significance can be derived for there being a higher 
number of defaulters in the TB-HIV group. The possible reasons for defaulting treatment can be 
related to side effect of both treatments as well as a high pill burden. We recognise the 
limitations of our study which were that not all case report forms had diagnosis for PLWHA and 
as such only symptoms were reported, all laboratory results outside of CD4 count and VL were 
not captured, the data was limited to an NGO clinic with adequate financial support with no 
comparison to a DOH clinic. This study showed that the NIMART is effective for PLWHA that 
are TB-HIV co-infected as it is for mono-infected patients when access to a medical officer for 
referral is available. We recommend that regular training on ART related adverse events on dual 
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Purpose of Protocol 
This protocol is submitted in partial fulfilment of the requirement for the Master of Public 
Health. The research component comprises 50% of the degree. The protocol will be submitted 
for ethical review to the Biomedical Research Ethics Committee (BREC) for expedited ethical 




Thirty Five million people are living with Human Immunodeficiency Virus (HIV) globally of 
which 25 million are in sub-Saharan Africa. The World Health Organization (WHO) in its 
efforts to reduce mortality introduced the concept of universal access to treatment for HIV by 
2015. The concept of task shifting from skilled personal such as doctors to less skilled personal 
such as nurses was introduced in resource constrained countries. South Africa initiated its policy 
in September 2010 that allowed the provision of antiretroviral medication to HIV infected 
patients by primary health care nurses. 
The purpose of the study is: 
To compare outcomes of nurse initiated management of antiretroviral therapy (NIMART) in 
TB- HIV co-infected patients vs HIV mono-infected patients in an urban non-government 
organization funded clinic in KwaZulu-Natal (KZN), from Jan 2011-Dec 2012.  
The specific objectives of this study are: 
1. To describe and compare the patient demographic variables and the HIV and AIDS disease 
profile in TB-HIV co infected patients’ vs HIV mono- infected patients. 
2. To analyze the difference between TB -HIV co-infected and HIV mono- infected   patients 
with regards to: 
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o Reasons for referrals of NIMART patients to the medical officer  
o Clinical outcomes 
o Laboratory outcomes 
o Mortality  
 
Research Methods  
The study is an observational, retrospective, analytical, cohort study. The study will be 
conducted at an urban NGO clinic in KZN, looking at HIV-TB co infected patients and HIV 
mono-infected patients (sample of 1000 patients). Data will be analyzed from case report forms; 
patient folder review and NIMART log sheets from nurses. Data analysis will incorporate both 
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NIMART                           Nurse Initiated Management of 
Antiretroviral Therapy 
HIV Human Immunodeficiency Virus 
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DOH Department of Health                      
TAC Treatment Action Campaign 
PLWH People living with HIV 
Up Microliter 
RCT Randomised Control Trial 
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KZN Kwa Zulu -Natal 
CAPRISA Centre for Aids Prevention Research in 
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1.               Introduction  
Thirty Five million people are living with HIV globally of which 25 million are in sub-Saharan 
Africa .1 Approximately 5 million people are living with HIV in South Africa (SA) 1. Globally 
there were 2.1 million new infections by the end of 2013 .1 
Since the discovery of HIV in 1981 an estimated 39 million people have died from Acquired 
Immune Deficiency Syndrome (AIDS). 2 
The World Health Organization (WHO) in its efforts to reduce mortality introduced the concept 
of universal access to treatment for HIV by 2015, which also encompasses Millennium 
Development Goal 6 .3 This goal is focused on combating HIV, AIDS, malaria and other 
diseases .3 The WHO global health strategy was implemented to achieve universal access to 
treatment and encompasses “reduce new infections by 50 percent among young people (15-24 
years), reduce tuberculosis (TB)-related mortality by 50 percent, eliminate new infections in 
children, and reduce HIV-related mortality” .3 
Access to universal treatment is not as simple as starting all eligible patients on treatment and  
involves challenges such as wide scale treatment access, trained healthcare staff, patient 
adherence, life -long commitment to treatment and  provision of effective antiretroviral therapy 
(ART) .3 
It is estimated that in Europe there are 8 times more nurses and 15 times more doctors than 
Africa .3 There are several reasons that exist for shortage of staff in poorer countries such has 
the incentive of working in wealthier countries and exposure to HIV. 3 
Primary health care nurses provide health care to thousands of patients both in rural and urban 
regions of SA and are a valuable resource for providing education, support and care for 
communities. 4, 5 
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These nursing practitioners often work under circumstances where access to a medical doctor is 
a scarce commodity and have to utilize their experience, skill and knowledge to provide a good 
quality of service to patients .4, 5 
The national government in SA had initiated a policy in September 2010 that allowed the 
provision of antiretroviral medication to HIV infected patients by primary health care nurses .4, 5 
It is evident that there are many challenges and lessons that can be learned from an established 
nurse based roll out program for ART. 
 
2. Literature Review 
The following section describes the background to the NIMART strategy, highlighting the need 
to overcome clinical staff shortages and initiatives to achieve the millennium development 
goals with regard to HIV rollout. The clinical trial summaries reflect the outcomes of various 
NIMART programmes and task shifting.   
 
2.1. The World Health Organisation strategy 
In 2008 the burden of HIV was expanding globally and the lack of highly trained personal to 
administer the treatment, lead the WHO to provide a global recommendation of task shifting. 6 
This was proposed with aim of overcoming the shortages of staff and being able to provide 
increased access to ART and meet the Millennium Development Goals. 6 ,8   The Sub-Saharan 
region was most affected with the HIV epidemic and thus task shifting would prove to be 






2.2. Task shifting 
Task shifting involved the transference of certain tasks which were performed by highly skilled 
personal such as doctors to less skilled personal such as nurses. 6 Task shifting has been shown 
in studies to allow higher access to HIV services with a result of greater efficiency of service 
delivery. 8 For example, the number of HIV treatment initiations due to task shifting doubled in 
Malawi .7 In Uganda there was an increase in enrolment of patients onto ARV program by 
19.7% .7  Task shifting was implemented in South Africa in 2010 .3 
 
2.3. National strategic plan and NIMART 
South Africa has a quadruple burden of disease which comprise of communicable diseases such 
as HIV/AIDS and TB, maternal and child morbidity and mortality, non- communicable disease 
as well as violence, injuries and trauma.9 
In line with the Millennium Development Goal 6 of combating HIV/AIDS, malaria and other 
diseases, and to address the SA burden of disease, the national strategic plan 2009-2014 for 
health was developed .3,9  One of the imperatives was to speed up the implementation of HIV / 
AIDS and Sexually Transmitted Infections National Strategic Plan from 2007-11 with an 
increase focus on TB and other communicable diseases. 9Analysis of South Africa s’ challenges 
led to the realization that HIV was a major contributor to morbidity and mortality and action 
needed to be taken to improve this outcome .9 Thus the government rolled out the NIMART 
program in 2010. 9  From 2010 to 2013 the number of people initiated on treatment increased 
from 923 000 to 1.9 million .9 The goal in South Africa is to achieve a HIV/AIDS free under 20 






2.4. Department of health (DOH) ART guidelines  
In South Africa the decade of HIV denialism was countered through the actions of the 
Treatment Action Campaign (TAC) who exerted pressure on the existing South African 
government to provide treatment and care for people living with HIV and AIDS (PLWHIV) .10   
In 2010 ARV treatment was provided to all PLWH that had a CD4 count of 200 cells per 
microliter (up) or less, with the exclusion of TB co-infected and pregnant females who were 
initiated on treatment with higher counts of 350 cell/up. 10 
By 2011 the guidelines were updated for ARV initiation to include all PLWH to start at CD4 
counts of 350 cells/ul or less. 10 By 2013 the guidelines were updated once again to initiate 
treatment with Antiretroviral drugs irrespective of their CD4 for PLWH co- infected with TB 
and all pregnant women.10   The massive shift in initiating ARV treatment at an earlier CD4 
count meant a scale up of HIV treatment programmes that required trained personal .14 
 
2.5. Evidence on NIMART 
The STRETCH trial which is interpreted as   “Task shifting of antiretroviral treatment from 
doctors to primary-care nurses in South Africa” was a parallel, cluster randomised controlled 
trial (RCT) conducted in 16 public sector clinics in the Free State during the period of 2008 to 
2010 .11   There were two cohorts of patients, patients waiting to start treatment and patients 
already on ART.11 The two cohorts deferred in terms of primary outcomes. Cohort one had an 
outcome of time to death and cohort two was undetectable viral loads 12 months after 
enrolment .11  Cohort one had 9252 participants and cohort two had 6231 participants .11 The 
results revealed that patients in cohort one had a 47% lower chance of death if they were on 
ART than those who were not and the study was able to attain the goal of viral load suppression 
in patients on treatment.11 This trial has demonstrated that task shifting is possible and that ART 
initiation and follow up can be done safely with nurses .11  Another RCT by Sanne et al. 
looking at nurse verse doctor management of HIV infected person also concluded that there was 




2.6. Sustainability of NIMART 
The success of NIMART has been proven in both the public sector as well as in non-
government organisations (NGO’S) with private funding. A study done by Naranbhai et al. 
conducted in a rural HIV clinic in KZN, showed that task shifting was able to influence positive 
long term treatment Outcomes .13  This study was conducted from 2004 to 2010, however the 
nurses were not involved in ART initiation but rather in the follow up of treatment initiated 
patients. 13 There was an onsite doctor for ART initiation and management of complications .13. 
Virological suppression was achieved in 89-97% of patients for period of 60 months and there 
was 82% retention even after 24 months .13 
Another cross sectional quality of care study in Khayelitsha in 2011 to 2012 showed that a 
clinical mentorship program improved clinical skills of nurses and boosted their confidence .14 
The South African government has since set a target of 85% for NIMART by 2016 .14 
A study conducted by the Foundation of Professional Development (FPD) in seven provinces in 
SA between 2010 and 2011 looked at the amount of nurses that were implementing NIMART 
within two months of patient’s attending the clinic. In addition quality of care and barriers to 
NIMART were evaluated. 14,15 The results indicated that only 72 % of nurses initiated treatment 
.14 Barriers   identified included lack of mentorship; training in pharmacology; clinical skills 
and shortage of primary health care nurses. 15  
The challenges highlighted within the above trials provide an insight as to the operational 




3. Purpose of the study 
To compare outcomes of nurse initiated management of antiretroviral therapy (NIMART) in 
TB- HIV co-infected patients vs HIV mono-infected patients in an urban non-government 
organization funded clinic in KwaZulu-Natal (KZN), from Jan 2011-Dec 2012. 
Hypothesis: NIMART management of TB-HIV patients is more complex to manage as 
compared to HIV mono-infected patients, thus   warranting   referral to a medical officer. 
4. Specific Objectives 
The following section identifies the specific objectives of the study which include both the 
description profile within a NIMART Programmed as well as an analysis of differences between 
the two cohorts. 
The specific objectives of this study are: 
4.1 To describe and compare the patient demographic variables and the HIV and AIDS disease 
profile in HIV-TB co infected patient’s vs HIV mono- infected patients. 
4.2 To analyze the difference between TB -HIV co-infected and HIV mono- infected   patients 
with regards to: 
o Reasons for referrals of NIMART patients to the medical officer  
o Clinical outcomes 
o Laboratory outcomes 




5. Type of research 
Health system research with population based epidemiological component 
 
6. Definitions 
The definitions listed below indicate specific definitions and how these would apply in the 
study: 
o NGO is defined as a non -government organization or non for profit organization.      The 
Term NGO used in this study refers to the center that has conducted the research within 
their urban site at EThekwini; 
o TB Staging: The current clinical classification system for TB is based on the pathogenesis 
of the disease. In this study the Centre for Disease classification will be used; 
o HIV WHO Staging: The WHO classification of HIV for adults and adolescents will be 
used for the purpose of this study. We will consider this in the present document, the 
category of adults and adolescents aged 15 years and over for surveillance purposes; 
o Urban:  Relating to, characteristic of, or constituting a city. For the purpose of the study 
the word urban refers to the setting in the city of Durban;  
o Rural: Rural Health Clinics must be located in communities that are both rural and 
underserved. References made to Rural Health Clinics, apply to those clinics outside the 
city on in Non-urbanized areas; 
o STATA: This is licensed statistical software used by statisticians for the purpose of 
statistical analysis. 
 
7. Research Methods 
The following section describes the research setting, methodology of sampling as well as data 
collection components required for data analysis. The statistical components for analysis are 




7.1 Study Setting 
The study setting is an urban NGO clinic in KZN.  The eThekwini clinic is part of the NGO 
CAPRISA (Centre for Aids Prevention Research in Southern Africa). The rollout program for 
the CAPRISA AIDS treatment (CAT) began in 2004 as an initiative to support the overburdened 
public sector to care for HIV infected patients. 
Patients were actively recruited from the DOH clinics situated next to the eThekwini clinic, 
where the staff offered voluntary counselling and HIV testing for patients visiting the clinic. 
Patients that tested HIV positive were extensively counselled and offered a CD4 count and an 
opportunity to join the antiretroviral rollout program which involved a network of support 
structures, counselling and antiretroviral provision as well as treatment and investigation of 
opportunistic infections.  
The antiretroviral provision had been initially done by doctors with the role of primary health 
care nurses reviewing patients clinically to assess eligibility and attending to clinically stable 
patients after six months on antiretroviral therapy. This trend had changed in 2010 in line with 
the national health department’s policy allowing nurses to initiate antiretroviral therapy. 
 
7.2 Study Design 
This study is an observational, retrospective, cohort study with an analytic component. 
 
7.3 Study population 
The study population consists of   TB-HIV co-infected and HIV mono- infected patients 
initiating ART at an urban NGO clinic in KZN from January 2011 to December 2012 by nurses.  
7.3.1 Inclusion / Exclusion Criteria 
7.3.1.1 Inclusion criteria: 
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o Adult patients age >18 
o Newly initiated patients on ART 
7.3.1.2 Exclusion criteria: 
o Patients <18 
o Patients already on ART 
o  
7.4 Study Sample 
The sample will be adult TB-HIV co-infected and HIV mono-infected patients initiated on ART. 
7.4.1 Method of selecting sample 
Simple random sampling will be performed for the selected patients.  Patients will be sampled 
from the total number of patients initiated between January 2011 and December 2012 by two 
nurses. 
7.4.2 Size of sample 
The sample size is 1000 patients. Based on the literature on mortality concerning mono HIV 
infected and TB-HIV co-infected patients. We estimated a sample size of 748 with a power of 
80% to detect a difference between 5.1% and 10.7% mortality among mono HIV infected   and 
TB-HIV co-infected patients respectively. However, we decided to use a sample size of 1000 
because the data was readily available. A sample size of 1000 increased the power to 85%. 
 
7.5 Data sources  
7.5.1 Measurement instruments and data collection techniques  
The data sources that will be reviewed are: 
o Case report forms in data fax;  
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o Laboratory results; 
o Patient folder review; and  
o NIMART log sheets captured by nurses. 
The above data sources have demographic, clinical, laboratory and pharmacological information 
which will be analyzed statistically. 
 
7.6 Measures to reduce selection bias and information bias 
The possible biases in study are: 
o Selection bias and we have planned on simple random sampling to overcome this bias. 
o Information bias and we have planned to conduct the retrospective review from 3 different 
data sources to verify the data and overcome this bias. 
o There will be no sample replacement with missing data and this will be accounted for in the 
analysis. 
o  
7.7 External Validity / Generalizability 
The reliability of data is maintained through simple random sampling and the results of the 
study can be generalizable to other similar urban communities in KwaZulu -Natal. 
 
7.8 Pilot study 






7.9 List of Variables  
The following list of variables is considered for the study: 
o Patient:  Age, race, sex, residence, female-pregnancy status; 
o Opportunistic infection staging for TB: The current clinical classification system for  TB is 
based on the pathogenesis of the disease; 
o Disease staging for HIV: The WHO classification of HIV for adults and adolescents will be 
used for the purpose of this study. We will consider the category of staging for adults and 
adolescents aged 15 years and over; 
o Laboratory: Creatinine and creatinine clearance, haemoglobin, alanine      aminotransferase 
(ALT), CD4 count and viral load at baseline, six months and twelve months; 
o Reasons for medical officer referrals; 
o Clinical : Adverse events, hospitalization, new opportunistic infections; 
o Mortality 
o Laboratory outcomes: (CD4 count and Viral load at baseline, six months and twelve 
months); 
o Incidence: Initiations of ART in both groups, failure to treatment.            
7.10 Plan for Data handling/processing 
Data will undergo data quality checks by researcher and the co-investigator. 
 
7.11 Statistical methods 
7.11.1 Descriptive statistics  
64 
 
 7.11.1.1 Data on patient characteristics   
The following data will be collected: 
o Age,  sex, race, residence; 
o Laboratory results: creatinine and creatinine clearance, haemoglobin, alanine  
aminotransferase,CD4 count, viral load;   
o Pregnancy status; 
o The WHO stage;  
o The TB stage 
 
The data description will include measures of central tendency such as the mean as well as 
measures for dispersion which will be the interquartile range. 
 
7.11.2   Analytic statistics 
The variables for the analysis for both the TB-HIV co-infected patients and HIV-mono infected 
patients are: 
o Reasons for medical officer referrals 
o Clinical outcomes(adverse events, hospitalisation ,new opportunistic infections ) 
o Mortality 
o Lab outcomes(CD4 count and viral load baseline,6 and 12 months),  
The unpaired T test will be included for continuous data, and the Fisher’s exact test for 
categorical data.  
Proportional- hazards regression models are to be used to adjust for confounding variables. 
Mortality will be analysed using the Kaplan-Meier curve and log-rank test.  




7.12 Summary of objectives, data collection and type of data analysis 
The section below summarizes the study objectives as well as the data collection and analysis.  
The specific objectives of this study are: 
1. To describe and compare the patient demographic variables and the HIV and AIDS disease 
profile in HIV mono- infected patients vs HIV-TB co infected patients  
2. To analyze the difference between TB -HIV co-infected and HIV mono- infected   patients 
with regards to: 
o Reasons for referrals of NIMART patients to the medical officer  
o Clinical outcomes 
o Laboratory outcomes 
o Mortality  
 
Data collection will be   from case report forms; patient folder review and NIMART log sheets 
from nurses. Simple random sampling will be done to overcome selection bias. The statistical 
analysis will consist of descriptive aspects which encompass patient characteristics. The 
analytical component which will include the, unpaired T test for continuous data and the   
Fisher’s exact test for categorical data. The proportional-hazards regression models will be used 
to adjust for confounding variables. Mortality will be analyzed using a Kaplan-Meier curve and 




7.13 Study limitations 
The data is limited to an NGO clinic that has adequate financial support with no comparison 
with a DOH clinic. 
Once the data has been analyzed, key findings and recommendations for the NIMART 
Programme   will be able to be concluded. 
 
8. Ethical Considerations 
The following sections consider ethical components required prior to and during the conduct of 
the study: 
8.1 Institutional Ethical Review Board 
This is a retrospective review of existing data thus no informed consent will be required, 
however relevant approvals need to be documented prior to commencement with the study 
analysis. 
 
9. Work Plan 
The following section indicates processes in the work plan to conduct the study. These include a 
study budget as well as timelines for accomplishing key milestones. 
9.1 Budget 
Please refer to appendix 1 for budget. The budget set also assesses final variance from budget 




9.2 Study Period/Timelines  
Please refer to appendix 2 for study timelines. 
The milestones set for each objective range from February 2015 to September 2016.  
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Budget for NIMHAART project from June 2015 to September 2016 
SOURCE AMOUNT 
INCOME R 0 
TOTAL EXPENSES R55000 
ACTUAL CLAIMED  
TOTAL SURPLUS/DEFICIT  
ITEMS:  
DATA MANAGEMENT: 
1.Data capture  
 
R   5 000 
2.Scientific writer R   7 000 
3.Statistician R 10 000 
4.Proof reader/Language editor R   5 000 
Others  
Fuel R      500         (5,55 per km) 
70 
 
Equipment R   1  000 
Stationery R   3  000 
Printing and copies R   2  000 
Telephone and fax R   2  000 
Postage and delivery R   2  500 
Consumables R   4  000 
Cell phone charges R   5  000      (500 per month )x 10 months 
3G usage R   5  000      (500 per month )x 10 month 
Publication  
Journal publication R    500 
Printing and binding thesis R 2 000 
Printing and binding reports R 1 000 














































√            
Protocol 
submission  
 √ √          
Development of 
tools 
√            
Data collection    √         
Data analysis     √        
Dissertation Write-up 
Draft 1      √       
Draft 2       √      
Draft 3        √     












































































Doris Duke Medical Research Institute (2nd floor), 719 Umbilo Road, Private Bag X7, 
Congella, 4013, Durban, South Africa tel: +27 31 2604555 | fax: +27 31 2604549 | email: 
caprisa@caprisa.org | www.caprisa.org 
 22 February 2016 
To whom it may concern, 
RE: Protocol Titled “Comparing he outcomes of nurse initiated management of 
antiretroviral therapy in tuberculosis-human immunodeficiency virus (HIV) co-
infected patients vs mono-infected patients in an urban non-government organisation 
funded clinic in KZN, from January 2011-December 2012 (BREC Ref. No.: BE494/15). 
I hereby grant permission for the PI of the abovementioned to use stored patient records 
at the  




Dr Kogieleum Naidoo .Head of Treatment Research CAPRISA  
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